MTOR and central nervous system cancer: Previous studies performed on glioma cell lines U251 MG and U‐87 MG have shown that deactivation of the mTOR signaling pathway by activation of AMPK (AMP‐activated protein kinase) with GSK621 leads to degradation of tetraspanin 8.45